A comprehensive insight into effects of green tea extract in polycystic ovary syndrome: a systematic review
- PMID: 34551795
- PMCID: PMC8459558
- DOI: 10.1186/s12958-021-00831-z
A comprehensive insight into effects of green tea extract in polycystic ovary syndrome: a systematic review
Abstract
Background: Polycystic ovary syndrome (PCOS), as the most common endocrine disorder in reproductive-aged women, is characterized by oxidative stress and ovarian tissue inflammation. Green tea extract (GTE) potentially possesses therapeutic effects for PCOS because of the antioxidant and anti-inflammatory compounds. This systematic review evaluates the potential roles of GTE on metabolic variables, hormone levels, and ovarian function in PCOS.
Methods: A systematic review was conducted of published studies reporting the effects of GTE on PCOS. Several major databases, including PubMed, SCOPUS, and Google Scholar, were searched up from inception to April 2021. Clinical trials and animal studies that assessed the effects of GTE on PCOS were eligible for inclusion.
Results: Of 314 articles found in the search, four human studies and four animal studies were included. All studies in humans showed the effects of GTE on weight loss. GTE's effect on decreasing testosterone levels in humans and LH levels in animals were also reported. In addition, increases in FSH and progesterone levels in animal models were observed. Although GTE improved fasting blood sugar and insulin levels, the effect of GTE on inflammatory parameters, such as TNF-alpha and IL-6 and antioxidant status, was limited to animal studies.
Conclusion: Therefore, this review suggests that GTE could be considered a potential agent to attenuate PCOS complications mainly due to its effect on weight loss and glycemic levels. However, more studies are needed to formulate conclusions about the effects and mechanisms of GTE in PCOS.
Keywords: Green tea extract; Insulin resistance; Polycystic ovary syndrome; Testosterone.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Potential roles of genistein in polycystic ovary syndrome: A comprehensive systematic review.Eur J Pharmacol. 2022 Oct 15;933:175275. doi: 10.1016/j.ejphar.2022.175275. Epub 2022 Sep 13. Eur J Pharmacol. 2022. PMID: 36108737 Review.
-
Effects of Tea Consumption on Anthropometric Parameters, Metabolic Indexes and Hormone Levels of Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Front Endocrinol (Lausanne). 2021 Dec 13;12:736867. doi: 10.3389/fendo.2021.736867. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34966355 Free PMC article.
-
Ficus deltoidea ameliorates biochemical, hormonal, and histomorphometric changes in letrozole-induced polycystic ovarian syndrome rats.BMC Complement Med Ther. 2021 Nov 29;21(1):291. doi: 10.1186/s12906-021-03452-6. BMC Complement Med Ther. 2021. PMID: 34844580 Free PMC article.
-
The Role of medicinal herbs in treatment of insulin resistance in patients with Polycystic Ovary Syndrome: A literature review.Biomol Concepts. 2020 Mar 26;11(1):57-75. doi: 10.1515/bmc-2020-0005. Biomol Concepts. 2020. PMID: 32229652 Review.
-
Therapeutic potentials of the natural plant flavonoid apigenin in polycystic ovary syndrome in rat model: via modulation of pro-inflammatory cytokines and antioxidant activity.Gynecol Endocrinol. 2020 Jul;36(7):582-587. doi: 10.1080/09513590.2019.1706084. Epub 2019 Dec 30. Gynecol Endocrinol. 2020. PMID: 31888395
Cited by
-
Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases-Focus on Epigenetic Mechanisms.Nutrients. 2024 Feb 17;16(4):559. doi: 10.3390/nu16040559. Nutrients. 2024. PMID: 38398883 Free PMC article. Review.
-
Effects of AIDiet intervention to improve diet quality, immuno-metabolic health in normal and overweight PCOS girls: a pilot study.Sci Rep. 2024 Feb 12;14(1):3525. doi: 10.1038/s41598-024-54100-1. Sci Rep. 2024. PMID: 38347150 Free PMC article.
-
The Effects of Plant-Derived Phytochemical Compounds and Phytochemical-Rich Diets on Females with Polycystic Ovarian Syndrome: A Scoping Review of Clinical Trials.Int J Environ Res Public Health. 2023 Aug 6;20(15):6534. doi: 10.3390/ijerph20156534. Int J Environ Res Public Health. 2023. PMID: 37569074 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous